Global (United States, European Union and China) Implantable Drug Delivery Devices Market Research Report 2019-2025

SKU ID : QYR- 13779509

Publishing Date : 09-Aug-2019

No. of pages : 116


  • Implantable drug delivery devices are used to administer drugs and fluids without the repeated insertion of needles. This product circumvents the need for patients to be hospitalized for intravenous infusion.
    Rise in incidence of chronic conditions is creating need for efficient medication delivery. Cancer results in highest number of deaths globally, raising the clinical urgency to adopt advanced alternatives, such as implantable drug delivery devices.
    In 2019, the market size of Implantable Drug Delivery Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
    In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Implantable Drug Delivery Devices.

    This report studies the global market size of Implantable Drug Delivery Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
    This study presents the Implantable Drug Delivery Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
    For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

    In global market, the following companies are covered:
    Allergan Inc.
    Bayer HealthCare
    Medtronic Inc.
    PSivida Corp.
    Boston Scientific Corporation
    Abbott Laboratories
    Bausch and Lomb Inc.

    Market Segment by Product Type

    Market Segment by Application
    Autoimmune Diseases

    Key Regions split in this report: breakdown data for each region.
    United States
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

    The study objectives are:
    To analyze and research the Implantable Drug Delivery Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Implantable Drug Delivery Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

    In this study, the years considered to estimate the market size of Implantable Drug Delivery Devices are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025